Silencing Prion Protein in MDA-MB-435 Breast Cancer Cells Leads to Pleiotropic Cellular Responses to Cytotoxic Stimuli

Guohua Yu(Qingdao University), Jiyan Ma(Shandong University of Technology)

PLoS ONE

November 2, 2012

10.1371/journal.pone.0048146

Cited by 20

Related Papers

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

|Journal of Clinical Oncology|2022|306

Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA

|Molecular Neurobiology|2018|49

Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation

|Cell Metabolism|2025|47

A multiple center, open-label, single-arm, phase II clinical trial of MRG002, an HER2-targeted antibody-drug conjugate, in patients with HER2-low expressing advanced or metastatic breast cancer.

|Journal of Clinical Oncology|2022|36

Quinoprotein Adducts Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced Toxicity in SH-SY5Y Cells

|Neurochemical Research|2011|25